Prostate cancer is a common illness among men, with a lifetime risk of one in seven. However, some men with prostate cancer are not diagnosed during their lifetime, leading to complications and death. The most well-known risk factors are age, race, and family history of prostate cancer. Age is a significant factor, with men above 70 years having a higher risk of developing the disease than younger men. Race also plays a role, with higher incidence rates among blacks than whites, while the risk is lowest among Asians. Family history, including breast and colon cancer, is also a significant risk factor, with hereditary genetic factors causing the illness in 5-10% of the cases. Genetic counseling benefits families with hereditary abnormalities in the BRCA1 and BRCA2 genes. Prostate cancer manifests in various ways in different communities worldwide, with variations caused by genetics, environmental factors, healthcare access, and screening and treatment differences. Certain dietary risk factors influence prostate cancer risk, such as fat and/or meat consumption, lycopene, and nutritional items, such as calcium and vitamin D. In addition, radiation therapy for prostate cancer as a first-line treatment has been linked to increased bladder and rectal cancers and carcinoid malignancies, and there is an increased risk of pancreatic cancer and melanoma. Finally, a rare autosomal dominant, highly penetrant gene allele might explain family clustering of illness among males with early-onset prostate cancer.
The United States Cancer Statistics (USCS) is the official source of federal cancer data and provides information on new cancer cases and deaths for the whole U.S. population. USCS Stat Bites are a new way for you to get cancer data. USCS Stat Bites summarizes the latest cancer cases, deaths, prevalence, and survival data on specific cancers. Summaries include the number of cancer cases diagnosed and cancer rates among men and women by age. USCS Stat Bites exist for lung, colorectal, prostate, and breast cancers. You can determine how these cancers affect men and women differently and get the survival rates.
